# Valsartan

## Diovan 80mg

| TAH Drug Code      | [ODIO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODIO){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension, heart failure and heart disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | HTN Initial: 80 -160 mg QD; slowly titrate up to maximum 320 mg QD CHF with reduced ejection fraction 20 -40 mg BID; doubling dose, every 1 to 2 weeks to 160mg BID Acute coronary syndromes: initial: 20mg BID may tolerance up to 160mg BID.                                                                                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Pregnancy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Headache, dizziness, viral infection, upper respiratory tract infection, diarrhea, coughing, fatigue, rhinitis, sinusitis, back pain, abdominal pain, nausea, pharyngitis, arthralgia. Cardiovascular: Hypotension Neurologic: Dizziness, Headache Renal: Serum blood urea nitrogen raised (heart failure, 16.6%; hypertension and post-myocardial infarction, not reported ), Serum creatinine raised (hypertension, 0.8%; heart failure, 3.9%; post-myocardial infarction, 4.2% ) Respiratory: Cough Other: Fatigue |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/valsartan-drug-information){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                            |

